# Aveir VR Coverage With Evidence Development Post-Approval Study

> **NCT05336877** · — · RECRUITING · sponsor: **Abbott Medical Devices** · enrollment: 8744 (estimated)

## Conditions studied

- Cardiac Pacemaker
- Arrythmia
- Bradycardia

## Interventions

- **DEVICE:** Aveir VR Leadless Pacemaker System
- **DEVICE:** Single-Chamber Transvenous Pacemaker

## Key facts

- **NCT ID:** NCT05336877
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-21
- **Primary completion:** 2028-01-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 8744 (ESTIMATED)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05336877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05336877, "Aveir VR Coverage With Evidence Development Post-Approval Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05336877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*